Fig. 4From: European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptylineSensitivity analysis of analysis for 50% or more reduction in monthly migraine days excluding a trial that reported on a 50% reduction in a migraine scoreBack to article page